How many employees work at Halozyme Therapeutics?
Halozyme Therapeutics, Inc. (HALO) has approximately 422 total employees worldwide as of March 2026, according to Revelio Labs workforce intelligence data. Halozyme Therapeutics’s total headcount has declined 3.6% from 437 employees in 2023 to 422 in 2026.
Is Halozyme Therapeutics hiring right now?
Yes, Halozyme Therapeutics is actively hiring. Halozyme Therapeutics had 36 active job postings in 2026, a 61.8% increase from 2025 — see job openings & hiring trends.
About Halozyme Therapeutics’s Workforce
Halozyme Therapeutics, Inc. (HALO) is a Pharmaceuticals company that employs 422 people worldwide as of March 2026. It is the 9th-largest by headcount among its peers. Founded in 1998, the company is headquartered in San Diego, California and trades on the NASDAQ.
Halozyme Therapeutics's workforce has declined 3.6% from 2023 to 2026, down 1.7% year over year in 2026. It fell to a low of 421 in 2025 Q3 before recovering. Its workforce is concentrated most in North America (81.9%), followed by Eastern Europe (4.6%) and South Asia (4.2%).
Halozyme Therapeutics's functional groups are Finance and Operations (47.1%), Engineering (29.6%), and Sales and Marketing (23.3%), with Sales and Marketing growing fastest (up 0.9%). The average salary is $154,025, ranging from a median of $149,000 in North America to $13,000 in South Asia, up 2.6% year over year in 2026.
Halozyme Therapeutics's active job postings rose 61.8% in 2026 to 36, with new postings per month cooling from 30 in 2023 to 11 in 2026. Overall employee sentiment is neutral but improving.
Sourced from Revelio Labs workforce data.
- Ticker
- NASDAQ: HALO
- Headquarters
- San Diego, California
- Founded
- 1998
- Industry
- Pharmaceuticals
- Employees
- 422
- YoY
- -1.7% (-2)
As of March 2026
Halozyme Therapeutics workforce metrics
Unlock hiring rate, attrition rate, and 12 additional workforce metrics for Halozyme Therapeutics. Compare to peers, export the dataset, and access the full quarterly history.
Unlock MetricsHalozyme Therapeutics Annual Employee Count (2023-2026)
- Halozyme Therapeutics had 422 employees in 2026, a 1.7% decline (-2) from 2025.
- Halozyme Therapeutics had 427 employees in 2025, a 0.5% decline from 2024.
- Halozyme Therapeutics had 427 employees in 2024, a 1.7% decline (-11) from 2023.
- Halozyme Therapeutics had 438 employees in 2023, a 0.3% decline (+15) from 2022.
Halozyme Therapeutics's total workforce has grown from 421 employees in 2025 to 422 in 2026. Halozyme Therapeutics's headcount peaked at 440 in 2023 before declining in 2025 and recovering through 2026.
Halozyme Therapeutics, Inc. quarterly employee count
| Year | Qtr | Employees | YoY Change | YoY % |
|---|---|---|---|---|
| 2026 | Q1 | 422 | -2 | -1.7% |
| 2025 | Q4 | 427 | +0 | -0.5% |
| 2025 | Q3 | 421 | -9 | -1.4% |
| 2025 | Q2 | 428 | +0 | +0.1% |
| 2025 | Q1 | 424 | -11 | -2.0% |
| 2024 | Q4 | 427 | -11 | -1.7% |
| 2024 | Q3 | 430 | -10 | -2.5% |
| 2024 | Q2 | 428 | -9 | -2.2% |
| 2024 | Q1 | 435 | +2 | -1.4% |
| 2023 | Q4 | 438 | +15 | -0.3% |
| 2023 | Q3 | 440 | +25 | +1.2% |
| 2023 | Q2 | 437 | +33 | +0.8% |
See Halozyme Therapeutics's complete headcount history, including quarterly breakdowns.
Get the DataHalozyme Therapeutics Employee Count by Region (2026)
North America accounts for the largest share of Halozyme Therapeutics's global workforce with approximately 82% of total employees, followed by Eastern Europe and South Asia.
Halozyme Therapeutics employees by region
| Region | Employees | % of Total |
|---|---|---|
| North America | 338 | 81.9% |
| Eastern Europe | 19 | 4.6% |
| South Asia | 17 | 4.2% |
| Southeast Asia | 8 | 1.8% |
| Northern Europe | 6 | 1.3% |
| Western Europe | 5 | 1.3% |
| Sub-Saharan Africa | 4 | 0.9% |
| Southern Europe | 3 | 0.8% |
| Pacific Islands | 3 | 0.8% |
| East Asia | 3 | 0.7% |
Drill into city-level data, hiring trends by region, and historic geographic shifts.
Unlock Geographic DataHalozyme Therapeutics Employee Count by Department (2026)
Halozyme Therapeutics's employee groups are Finance and Operations (47.1%), Engineering (29.6%), and Sales and Marketing (23.3%).
Halozyme Therapeutics employees by department
| Department | Employees | % of Total |
|---|---|---|
| Finance and Operations | 193 | 47.1% |
| Engineering | 121 | 29.6% |
| Sales and Marketing | 95 | 23.3% |
Compare Halozyme Therapeutics's department mix to industry peers.
See Full DataHalozyme Therapeutics Employee Salary by Region (2026)
Halozyme Therapeutics's average employee salary is $154,025 globally. Employees in North America receive the highest compensation. Pay is lowest in South Asia, at a median of $13,000.
Halozyme Therapeutics median employee salary by region (USD)
| Region | Median Salary |
|---|---|
| North America | $149,000 |
| Pacific Islands | $72,000 |
| Northern Europe | $63,000 |
| Western Europe | $47,000 |
| Eastern Europe | $31,000 |
| East Asia | $30,000 |
| Arab States | $27,000 |
| Central and Western Asia | $26,000 |
| Southern Europe | $19,000 |
| South America | $18,000 |
| Southeast Asia | $16,000 |
| South Asia | $13,000 |
| Sub-Saharan Africa | $9,000 |
| North Africa | $8,000 |
Unlock salary by role, level, and city — and compare to Halozyme Therapeutics's industry peers.
Unlock Salary DataHalozyme Therapeutics Job Openings and Hiring Trends (2023-2026)
- Halozyme Therapeutics had 36 active job postings in 2026, a 61.8% increase (-7) from 2025.
- Halozyme Therapeutics had 43 active job postings in 2025, a 52.9% increase (+18) from 2024.
- Halozyme Therapeutics had 25 active job postings in 2024, a 8.3% increase (+2) from 2023.
- Halozyme Therapeutics had 23 active job postings in 2023, a 60.6% decline from 2022.
- Hiring velocity in 2026: 11 new roles/month, down from 14 in 2025 and 18 in 2024.
Halozyme Therapeutics's active job postings rose 61.8% in 2026 to 36, with new postings per month cooling from 30 in 2023 to 11 in 2026.
Track new postings per month, role-level demand, and hiring velocity vs. peers.
Unlock Hiring DataHalozyme Therapeutics Employee Sentiment (2026)
Revelio Labs tracks employee sentiment across Halozyme Therapeutics's workforce based on public professional data. Overall sentiment is neutral and has improved year over year in 2026.
Overall
Unlock the full sentiment breakdown by department, tenure, and trend over time.
Unlock SentimentSimilar Companies
Similar Pharmaceuticals Companies by Employee Count
Frequently Asked Questions About Halozyme Therapeutics
- How fast is Halozyme Therapeutics growing?
- In 2026, Halozyme Therapeutics's headcount shrank 1.7% to 422 employees, down from 424 in 2025.
- See the full headcount history
- Where are Halozyme Therapeutics employees located?
- Most Halozyme Therapeutics employees are based in North America (81.9% of headcount), followed by Eastern Europe and South Asia.
- Explore where the workforce is based
- What is the average salary at Halozyme Therapeutics?
- The average employee salary at Halozyme Therapeutics is approximately $154k per year.
- Analyze the salary distribution
- How many new job postings does Halozyme Therapeutics open per year?
- In Q1 2026, Halozyme Therapeutics opened 34 new job postings. In 2025, Halozyme Therapeutics opened 163 new job postings — about 14 per month.
- Track hiring trends by role
- When was Halozyme Therapeutics founded and where is it headquartered?
- Halozyme Therapeutics was founded in 1998 and is headquartered in San Diego, California.
- Compare Halozyme Therapeutics to industry peers
Speak with a workforce expert about Halozyme Therapeutics.
Book a DemoSee something that doesn't look right? Reach out and our team will review it.